(3R,9aS)-2-(4-Methoxy-benzenesulfonyl)-5-oxo-octahydro-pyrrolo[1,2-a][1,4]diazepine-3-carboxylic acid hydroxyamide

ID: ALA6572

PubChem CID: 10407603

Max Phase: Preclinical

Molecular Formula: C16H21N3O6S

Molecular Weight: 383.43

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)N2C[C@@H]3CCCN3C(=O)C[C@@H]2C(=O)NO)cc1

Standard InChI:  InChI=1S/C16H21N3O6S/c1-25-12-4-6-13(7-5-12)26(23,24)19-10-11-3-2-8-18(11)15(20)9-14(19)16(21)17-22/h4-7,11,14,22H,2-3,8-10H2,1H3,(H,17,21)/t11-,14+/m0/s1

Standard InChI Key:  QPEZTCMCOIDQRV-SMDDNHRTSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  1  0  0  0  0  0999 V2000
    4.6750   -2.6042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750   -1.7792    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9250   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7500   -3.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2667   -4.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0875   -4.4042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4125   -2.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -2.6042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6000   -3.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4750   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8750   -1.9917    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4625   -0.9792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9125   -5.1542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.2500   -1.7792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5375   -3.0167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0500   -2.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6750   -0.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5500   -5.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0500   -1.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8417   -1.9167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4625   -0.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8250   -2.6042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3750   -4.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8500   -0.9042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3417   -4.8667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4375   -1.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3510   -3.1064    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  1  0
  5  4  1  0
  6  9  1  0
  7  1  1  0
  3  8  1  6
  9  7  1  0
 10  2  1  0
 11  2  2  0
 12  2  2  0
 13  5  2  0
 14  8  2  0
 15  8  1  0
 16 10  2  0
 17 10  1  0
 18  6  1  0
 19 21  1  0
 20 16  1  0
 21 17  2  0
 22 15  1  0
  9 23  1  0
 24 19  1  0
 25 23  1  0
 26 24  1  0
  6  5  1  0
 18 25  1  0
 20 19  2  0
  9 27  1  1
M  END

Associated Targets(Human)

MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP3 Tchem Matrix metalloproteinase 3 (3433 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP7 Tchem Matrix metalloproteinase 7 (1073 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mmp13 Matrix metalloproteinase 13 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 383.43Molecular Weight (Monoisotopic): 383.1151AlogP: -0.05#Rotatable Bonds: 4
Polar Surface Area: 116.25Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.71CX Basic pKa: CX LogP: -0.60CX LogD: -0.62
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.56Np Likeness Score: -0.97

References

1. Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE..  (2001)  Heterocycle-based MMP inhibitors with P2' substituents.,  11  (8): [PMID:11327577] [10.1016/s0960-894x(01)00137-8]

Source